These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15487966)

  • 1. Multiple analyses in clinical trials: sound science or data dredging?
    Lord SJ; Gebski VJ; Keech AC
    Med J Aust; 2004 Oct; 181(8):452-4. PubMed ID: 15487966
    [No Abstract]   [Full Text] [Related]  

  • 2. Cut-points for the measurement of pain: the choice depends on what you want to study.
    Farrar JT
    Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
    [No Abstract]   [Full Text] [Related]  

  • 3. The limitations of small outcome studies.
    Gibbons RJ; Hodge D
    J Nucl Cardiol; 2012 Apr; 19(2):230-2. PubMed ID: 22359226
    [No Abstract]   [Full Text] [Related]  

  • 4. Pitfalls in statistical methods.
    Gao F; Machin D
    J Nucl Cardiol; 2013 Aug; 20(4):650-1. PubMed ID: 23674190
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitfalls in statistical methods.
    Petretta M; Cuocolo A
    J Nucl Cardiol; 2012 Aug; 19(4):818; author reply 819. PubMed ID: 22674446
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.
    Grundman M; Gilman S; Black RS; Fox NC; Koller M
    Neurology; 2008 Aug; 71(9):697; author reply 697-8. PubMed ID: 18725601
    [No Abstract]   [Full Text] [Related]  

  • 7. What's new in trial design: propensity scores, equivalence, and non-inferiority.
    Myles PS
    J Extra Corpor Technol; 2009 Dec; 41(4):P6-10. PubMed ID: 20092080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: Logistic regression, odds ratio, and factor variables.
    Petretta M; Cuocolo A
    J Nucl Cardiol; 2013 Aug; 20(4):652-3. PubMed ID: 23670351
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply: Correlation between clinical outcomes and appropriateness grading for referral to myocardial perfusion imaging for preoperative evaluation prior to non-cardiac surgery.
    Koh AS; Chua T
    J Nucl Cardiol; 2013 Aug; 20(4):654. PubMed ID: 23475439
    [No Abstract]   [Full Text] [Related]  

  • 10. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Khan OA; Tselis A; Boster A
    Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of multiple ordinal endpoints.
    Häberle L; Pfahlberg A; Gefeller O
    Biom J; 2009 Feb; 51(1):217-26. PubMed ID: 19197963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of clinical significance.
    Turner JA; Turk DC
    Pain; 2008 Jul; 137(3):467-468. PubMed ID: 18455313
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to change the primary outcome of lupus trials.
    Houssiau FA
    Ann Rheum Dis; 2019 May; 78(5):581-582. PubMed ID: 29921574
    [No Abstract]   [Full Text] [Related]  

  • 15. Gatekeeping procedures with clinical trial applications.
    Dmitrienko A; Tamhane AC
    Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partition testing in dose-response studies with multiple endpoints.
    Liu Y; Hsu J; Ruberg S
    Pharm Stat; 2007; 6(3):181-92. PubMed ID: 17654696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endpoints in respiratory diseases.
    de Benedictis FM; Guidi R; Carraro S; Baraldi E;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():49-59. PubMed ID: 21104409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressing towards acceptable treatment outcomes.
    Vowles KE; Robinson ME
    Pain; 2009 Aug; 144(3):228-229. PubMed ID: 19500909
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal composite scores for longitudinal clinical trials under the linear mixed effects model.
    Ard MC; Raghavan N; Edland SD
    Pharm Stat; 2015; 14(5):418-26. PubMed ID: 26223663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Trials, End Points, and Statistics-Measuring and Comparing Cancer Treatments in Practice.
    West H; Dahlberg S
    JAMA Oncol; 2018 Dec; 4(12):1798. PubMed ID: 30193254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.